Vaxcyte, Inc. (PCVX)
69.71
-1.67
(-2.34%)
USD |
NASDAQ |
Oct 12, 14:10
Vaxcyte Free Cash Flow (Quarterly) : -237.04M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -237.04M |
| March 31, 2026 | -295.42M |
| December 31, 2025 | -233.25M |
| September 30, 2025 | -155.35M |
| June 30, 2025 | -130.92M |
| March 31, 2025 | -193.02M |
| December 31, 2024 | -141.43M |
| September 30, 2024 | -98.79M |
| June 30, 2024 | -166.77M |
| March 31, 2024 | -164.80M |
| December 31, 2023 | -185.88M |
| September 30, 2023 | -64.89M |
| June 30, 2023 | -60.60M |
| March 31, 2023 | -53.30M |
| December 31, 2022 | -66.37M |
| Date | Value |
|---|---|
| September 30, 2022 | -39.39M |
| June 30, 2022 | -40.06M |
| March 31, 2022 | -30.62M |
| December 31, 2021 | -52.48M |
| September 30, 2021 | -30.13M |
| June 30, 2021 | -30.89M |
| March 31, 2021 | -14.45M |
| December 31, 2020 | -11.49M |
| September 30, 2020 | -13.08M |
| June 30, 2020 | -9.124M |
| March 31, 2020 | -14.08M |
| December 31, 2019 | -16.46M |
| September 30, 2019 | -9.518M |
| June 30, 2019 | -13.68M |
| March 31, 2019 | -9.784M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Moderna, Inc. | -563.00M |
| Vir Biotechnology, Inc. | 123.29M |
| Revolution Medicines, Inc. | -389.60M |
| Arrowhead Pharmaceuticals, Inc. | -181.32M |
| Oncolytics Biotech, Inc. | -8.066M |